🔎 Trials Near Me

Home › Acute Myeloid Leukemia › Arizona › Phoenix

Pag-aaral pangklinika para sa Acute Myeloid Leukemia sa Phoenix, AZ

Isang pag-aaral para sa Acute Myeloid Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Phoenix. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Nagre-recruitPhase 2
  • Mayo Clinic Hospital in Arizona, Phoenix
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05564390

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • Cancer Center at Saint Joseph's, Phoenix
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Nagre-recruitPhase 2
  • Mayo Clinic Hospital in Arizona, Phoenix
Edad 18 hanggang 59 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT05554406

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Nagre-recruitPhase 3
  • Phoenix Childrens Hospital, Phoenix
6 Months – 21 Years · Lahat ng kasarian · Na-update Set 17, 2026 · NCT04293562

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Nagre-recruitPhase 2
  • Mayo Clinic Arizona, Phoenix
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT04996875

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Nagre-recruitPhase 1/2
  • Mayo Clinic, Phoenix
Edad 12 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT04588922

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Nagre-recruitPhase 3
  • Phoenix Children's Hospital, Phoenix
29 Days – 21 Years · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05183035

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Nagre-recruitObservasyonal na pag-aaral
  • Phoenix Children's Hospital, Phoenix
Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545

Caris Chromoseq Data Collection

Nagre-recruitObservasyonal na pag-aaral
  • Caris Life Sciences, Phoenix
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT07680868

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

Nagre-recruitPhase 1
  • Phoenix Children's Hospital, Phoenix
Hanggang edad 21 · Lahat ng kasarian · Na-update Abr 22, 2026 · NCT05101551

A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

Nagre-recruitPhase 1/2
  • Mayo Clinic Arizona, Phoenix
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT05732103

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Nagre-recruitPhase 1
  • Mayo Clinic - Phoenix, Phoenix
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT05735184

Pag-aaral para sa Acute Myeloid Leukemia sa ibang lungsod

Iba pang pag-aaral sa Phoenix

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.